02-Nov-09 AMEDISYS releases report from Marwood Group Advisory; Marwood believes co has implemented compliance and quality improvement processes that meet and/or exceed the industry average (39.79 ) AMED engaged Marwood to provide an independent analysis of the company's procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies. Marwood conducted a review of academic research, over 11,000 pages of company specific documents, interviews with 18 members of company leadership, and interviews with a cross section of other home health providers from across the nation, and utilized its home health industry, legislative and regulatory knowledge to measure industry standards, best practices and leading practices to evaluate the Amedisys model and infrastructure. Co says the results showed that AMED ranked highest compared to other publicly traded home health companies in terms of quality improvement and compliance processes. Among their findings, Marwood stated, "Amedisys also employs best practices in the areas of field clinician coding and accuracy, oversight and management infrastructure, corporate compliance, and care coordination technology." They further state, "Based on our Quality and Compliance Process Scorecard and information collected during our review of Company documentation and onsite interviews, Marwood believes that, overall, Amedisys has implemented compliance and quality improvement processes that meet and/or exceed the industry average."
Ha! Guess they missed the whole therapy utilization thing. This firm has no clinicians on staff and would have not been able to determine whether or not therapy visits were clinically necessary. How often does it happen that the firm hired by the company is the one to actually blow the whistle? Oh yes, NEVER!